Compass Biomedical
Industry
- Biotechnology
- Contract Research Organization-CRO
Other Names/Subsidiaries
- Arteriocyte, Inc.
Latest on Compass Biomedical
In Vitro Diagnostics Alliances / In Vitro Diagnostics Affymetrix Inc. Affymetrix netted $269.5mm through the sale of unsecured 3.5% senior convertible notes due 2038. The notes convert at $30.12 pe
Diabetes Poor Acceptance Dooms Exubera Inhaled Insulin Pfizer Inc. took the diabetes industry by surprise in October when it announced it would discontinue sales of Exubera inhaled insulin, after
Biotech start-ups build on known approaches, not novel targets, for this complex syndrome. Heart failure (HF), like cancer, is a major killer--in the US alone, 5.2 million people die from it; another
Grafts and corruption. This is a problem in Europe, as in the rest of the world, medically speaking that is. Many prevalent diseases cause vessel damage that necessitates replacement vascular grafts,